Patent ID: 7052830
Filing Date: 2006-05-30
Classification: A61K,A61P,C07K,C12N

Abstract:
1. A method of diagnosing Hepatitis C virus (HCV) infection, comprising contacting a biological sample from a subject with an antibody or antigen binding portion thereof that specifically binds to a polypeptide comprising an amino acid sequence of at least 8 amino acids in length which amino acid sequence is encoded by an HCV nucleic acid molecule comprising a nucleotide sequence corresponding to SEQ ID NO:1 and translated in a reading frame corresponding to the reading frame of SEQ ID NO:1 and +1 to the standard HCV reading frame, under conditions where the polypeptide and the antibody or antigen binding portion thereof can bind, determining the presence or absence of the polypeptide, wherein presence of the polypeptide indicates infection with HCV.